Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-108958
Filing Date
2016-03-31
Accepted
2016-03-31 14:59:56
Documents
6
Effectiveness Date
2016-03-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A a16-7221_3defa14a.htm DEFA14A 49114
2 GRAPHIC g72213bgi001.gif GRAPHIC 12935
3 GRAPHIC g72213bmi001.gif GRAPHIC 71000
4 GRAPHIC g72213bmi002.gif GRAPHIC 69409
5 GRAPHIC g72213bmi003.gif GRAPHIC 34535
6 GRAPHIC g72213bmi004.gif GRAPHIC 27835
  Complete submission text file 0001104659-16-108958.txt   348013
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35558 | Film No.: 161543045
SIC: 2836 Biological Products, (No Diagnostic Substances)